Chapter 4

Category and Moat

Vital Farms sits in the fastest-growing corner of a large, staple category, and it is gaining share there: pasture-raised egg volume grew about 27% a year from 2020 to 2025 while conventional eggs shrank, and household penetration climbed from roughly 2% at the 2020 IPO to about 10.5% [1]. The demand is structural. The moat protecting it is a brand and a farmer network, not a cost or a patent — and it is now being tested by private label and by far larger, better-capitalized producers.

The category is a structural shift, not a fad

The case for durable growth starts with where the volume is going. Across 2020 to 2025, pasture-raised was the only egg segment growing fast — about 27% a year by volume — while conventional eggs, still the bulk of the market, declined about 6% a year and the mid-tier cage-free and free-range segments grew around 12% [2]. This is consumers trading up within an everyday purchase, not a novelty spike.

Source: 2025 Investor Day presentation, Circana segment volume data [3].

The same pattern shows up in dollars and in penetration of the shelf. Eggs from hens with outdoor access rose from 5.7% of U.S. shell-egg volume in 2020 to 13.0% in 2025 [4], and the pasture-raised retail egg market reached roughly $1.3 billion in 2025, compounding about 37.5% a year since 2021 [5]. That $1.3 billion is still only a sliver of the roughly $15.4 billion U.S. shell-egg market [6] — the runway argument in one number.

Source: FY2025 Annual Report, Industry Overview (Circana retail-sales data); Vital Farms net revenue as reported [7].

One caution belongs on the shell-egg number: the reported 21.3% category CAGR since 2021 is inflated by avian-influenza-driven egg-price spikes, not by unit demand. The U.S. egg-laying flock was still about 301 million birds in September 2025, below the roughly 341 million of January 2020 [8]. The durable signal is the volume mix shift toward outdoor access, not the headline dollar growth.

The runway: penetration is low, and buyers stay

Vital Farms reaches about 10.5% of U.S. households against category penetration near 97% [9] — nearly 16 million homes, served through roughly 24,000 stores [10]. Penetration has more than doubled since the 2020 IPO.

Source: company filings and earnings calls — 2020 IPO prospectus and FY2021–FY2022 10-Ks (SPINS); 2023–2024 per the Q4 FY2024 call; 2025 per the FY2025 10-K (Circana) [11]; [12].

Two things temper the runway read. First, the climb flattened: penetration was 10.7% in 2024 and about 10.5% in 2025 (the measurement source also shifted from SPINS to Circana), so the 25% revenue gain in 2025 came from existing buyers purchasing more, not from a widening base [13]. Second, the offsetting strength is real: when Vital Farms adds a household it tends to keep it, buy rate rose 12% to $36.06 in 2024, and brand awareness climbed 8 points to 34% in 2025 [14]. The growth model has shifted from "more doors" (Pasture-Raised at Scale) to "more homes and deeper baskets," and the deeper-basket half is doing the heavier lifting.

Vital is winning share — the moat is a brand and a network

Within this category Vital Farms is the leader and still gaining. It is the #1 U.S. pasture-raised brand, #1 in the natural channel, and #2 U.S. egg brand overall by retail dollar sales [15], and it was the top volume-share gainer among premium shell-egg brands in 2025, adding 25 basis points of share (35 basis points in early 2026) [16]. As of December 2025 it was the number-one or number-two branded egg at nine of its ten largest customers [17].

The moat has three parts, and all three are brand- or relationship-based rather than structural. It is a trusted consumer brand built on transparency and animal welfare; a contracted network of more than 600 family farms operating to the Certified Humane pasture-raised standard of 108 square feet of outdoor space per hen, hard to assemble at national scale; and a set of retailer relationships in which Vital's eggs earn premium shelf economics. None of these is a cost advantage or a patent. That is the central fact about the moat: it is durable only as long as the brand keeps commanding a premium and the farmer network stays ahead of demand.

The two-sided test: private label and larger rivals

The premium is being probed from two directions, and this is where a cautious reader should linger rather than accept the leader's framing.

Private label is entering the category Vital created. Private-label pasture-raised eggs grew from about 0.1% of U.S. shell-egg volume in 2020 to 1.0% in the first half of 2025 — while Vital's own share rose from 1.0% to 3.2% over the same span [18].

Source: August 2025 corporate presentation, Circana volume-share data (2025 is first-half) [19].

Management's read is that private label is expanding the category rather than taking from brands — pulling commodity-egg buyers up into outdoor access, not converting Vital's customers [20], and the CEO has called private label's ability to trade its own shoppers up "quite strong" and a validation of the category [21]. The skeptical counter is on the same chart: private-label pasture-raised volume share grew roughly ten-fold over five years against Vital's roughly three-fold, so private label is the faster-growing entrant even if it is smaller, and it now equals about a third of Vital's shell-egg share, up from a tenth in 2020. A related tell sits in the filings themselves — the 2021 10-K quantified Vital's grip as an 88% share of the U.S. pasture-raised retail egg market [22]; the FY2025 10-K repeats the "#1 pasture-raised" claim but no longer discloses a category share [23]. The most likely reason a company drops a share statistic is that the number moved the wrong way.

Larger, better-capitalized producers are moving into premium eggs. Vital's own risk factors describe an industry "dominated by multinational corporations with substantially greater resources," warn that conventional food companies may acquire competitors or launch their own premium products, and note increasing consolidation among specialty-egg companies [24]. This is not hypothetical. Cal-Maine Foods — the largest U.S. egg producer — already sells pasture-raised eggs under its Farmhouse Eggs and Egg-Land's Best brands, markets private-label specialty eggs to retailers, and is expanding specialty capacity through acquisitions [25]. A commodity producer with national scale, low-cost hens, and an M&A budget is a different kind of competitor than the small branded rivals Vital outgrew on the way up.

The premium is discretionary, and 2026 showed what that costs. When commodity egg prices collapsed in early 2026, the gap between a carton of Vital Farms and a carton of store-brand eggs widened, trial slowed, and some shoppers traded down — the mechanism examined in Cash Conversion. That episode is the clearest evidence that the moat is cyclically exposed: the brand commands a premium in normal times, but the size of that premium — and therefore trial and mix — moves with a commodity price Vital does not control. A moat that holds in good conditions and narrows in a commodity glut is real, but it is not the fortress a leader's market-share language implies.

What the evidence supports, and what would change it

The weight of the evidence is that the category is a durable, structurally-growing shift with a long runway — pasture-raised is genuinely the fastest-growing segment, penetration is low against a near-universal category, and Vital is the clear leader still gaining share. The strongest fact against a clean bull read is that the protection around that lead is a brand premium, not a cost or supply advantage, and that premium is being pressured on price by private label, on capital and scale by much larger entrants, and on trial by the commodity cycle. The read that fits both sides: a strong position in a good category, defended by a moat that is real but narrower and more cyclical than the "#1" framing suggests.

Three things would move the assessment. Penetration resuming its climb above roughly 10.5% would confirm the runway is still opening rather than maturing; the reverse would say the accessible base is closer to full. Vital holding or extending its share as private-label pasture-raised scales — rather than the two converging — would show the brand premium survives contact with a cheaper shelf equivalent. And pricing power holding through the next commodity swing, with the premium and trial stable rather than compressing, would tell whether the moat is durable or merely fair-weather.